CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −4,000 | $25.78 | $103K | 385,683 |
| 2026-11-04 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −7,881 | $26.60 | $210K | 377,802 |
| 2026-11-04 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 82,752 | ||
| 2026-11-03 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-03 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $25.98 | $309K | 377,802 |
| 2026-11-03 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 94,633 | ||
| 2026-11-02 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-02 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −9,296 | $25.23 | $235K | 380,387 |
| 2026-11-02 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −2,585 | $26.34 | $68K | 377,802 |
| 2026-11-02 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 106,514 | ||
| 2026-10-30 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-30 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −9,486 | $26.55 | $252K | 380,197 |
| 2026-10-30 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −2,395 | $27.45 | $66K | 377,802 |
| 2026-10-30 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 118,395 | ||
| 2026-10-29 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-29 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $28.27 | $336K | 377,802 |
| 2026-10-29 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 130,276 | ||
| 2026-10-28 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-28 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,681 | $28.44 | $332K | 378,002 |
| 2026-10-28 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −200 | $28.90 | $6K | 377,802 |
Page 2 of 119 · 2,375 trades